Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:1057 (5 November), doi:10.1136/bmj.38618.580903.AE (published 10 October 2005)
D A Fitzmaurice, professor of primary care1, E T Murray, research fellow1, D McCahon, research associate1, R Holder, head of statistics1, J P Raftery, professor of health economics2, S Hussain, statistician1, H Sandhar, IT officer1, F D R Hobbs, head of department1
1 Department of Primary Care, University of Birmingham, Birmingham, 2 Health Services Management Centre, Birmingham B15 2RT
Correspondence to: D A Fitzmaurice d.a.fitzmaurice{at}bham.ac.uk
Objective To determine the clinical effectiveness of self management compared with routine care in patients on long term oral anticoagulants.
Design Multicentre open randomised controlled trial.
Setting Midlands region of the UK.
Participants 617 patients aged over 18 and receiving warfarin randomised to intervention (n = 337) and routine care (n = from 2470 invited; 193/337 (57%) completed the 12 month intervention.
Intervention Intervention patients used a point of care device to measure international normalised ratio twice a week and a simple dosing chart to interpret their dose of warfarin.
Main outcome measure Percentage of time spent within the therapeutic range of international normalised ratio.
Results No significant differences were found in percentage of time in the therapeutic range between self managment and routine care (70% v 68%). Self managed patients with poor control before the study showed an improvement in control that was not seen in the routine care group. Nine patients (2.8/100 patient years) had serious adverse events in the self managed group, compared with seven (2.7/100 patient years) in the routine care arm (
2(df = 1) = 0.02, P = 0.89).
Conclusion With appropriate training, self management is safe and reliable for a sizeable proportion of patients receiving oral anticoagulation treatment. It may improve the time spent the therapeutic range for patients with initially poor control.
Trial registration ISRCTN 19313375.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses